Published in Mol Cell Biol on August 01, 2000
Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol (2001) 2.72
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol (2004) 2.20
Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One (2008) 2.12
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci U S A (2005) 1.91
Nuclear functions of the HMG proteins. Biochim Biophys Acta (2009) 1.63
The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res (2010) 1.47
HMGA2 participates in transformation in human lung cancer. Mol Cancer Res (2008) 1.44
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res (2008) 1.43
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias. Blood (2011) 1.36
Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci U S A (2005) 1.36
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol (2003) 1.32
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol (2001) 1.26
HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One (2013) 1.25
HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One (2012) 1.25
HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics (2011) 1.19
Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Mol Cancer Res (2009) 1.15
HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One (2012) 1.15
HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod Pathol (2009) 1.14
Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leuk Lymphoma (2011) 1.07
Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network. BMC Syst Biol (2008) 1.05
Transcriptional enhancers in protein-coding exons of vertebrate developmental genes. PLoS One (2012) 1.03
HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol (2009) 1.01
Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. J Invest Dermatol (2013) 1.00
A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. J Virol (2012) 0.98
High-mobility group A1 proteins are overexpressed in human leukaemias. Biochem J (2003) 0.93
Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay. Anal Biochem (2007) 0.90
Role of miRNA let-7 and its major targets in prostate cancer. Biomed Res Int (2014) 0.89
Deregulation of common genes by c-Myc and its direct target, MT-MC1. Proc Natl Acad Sci U S A (2005) 0.89
Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice. Cell Res (2011) 0.88
Determining significance of pairwise co-occurrences of events in bursty sequences. BMC Bioinformatics (2008) 0.88
The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochem Funct (2012) 0.87
Hitting the bull's eye: targeting HMGA1 in cancer stem cells. Expert Rev Anticancer Ther (2014) 0.86
The high mobility group A1 molecular switch: turning on cancer - can we turn it off? Expert Opin Ther Targets (2014) 0.84
HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma (2013) 0.84
RNA-Mediated Regulation of HMGA1 Function. Biomolecules (2015) 0.83
The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology (2012) 0.82
HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency. Mol Cell Biol (2009) 0.82
Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis. PLoS One (2013) 0.81
MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis. PLoS One (2011) 0.81
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis. Neoplasia (2008) 0.79
Widespread genomic instability mediated by a pathway involving glycoprotein Ib alpha and Aurora B kinase. J Biol Chem (2010) 0.79
Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro. Am J Transl Res (2016) 0.77
The Quest for Targets Executing MYC-Dependent Cell Transformation. Front Oncol (2016) 0.76
Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells. Exp Mol Med (2016) 0.75
HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche. Nat Commun (2017) 0.75
RNA-Mediated Regulation of HMGA1 Function. Biomolecules (2015) 0.75
High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma. Surgeon (2009) 0.75
Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21). Int J Oncol (2015) 0.75
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development. Curr Mol Med (2016) 0.75
Anti-Transcription Factor RNA Aptamers as Potential Therapeutics. Nucleic Acid Ther (2015) 0.75
Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. World J Stem Cells (2013) 0.75
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14
Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell (1983) 9.03
c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol (1999) 8.17
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
MYC oncogenes and human neoplastic disease. Oncogene (1999) 7.28
Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell (1995) 7.17
The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell (1992) 5.85
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res (1982) 5.14
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ (1997) 5.14
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell (1982) 4.84
The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A (1993) 4.66
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Expression of cellular oncogenes in human malignancies. Science (1984) 4.48
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science (1991) 4.45
Assay of transforming activity of tumor virus DNA. Methods Enzymol (1980) 4.31
An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol (1990) 4.24
Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (1996) 4.23
Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell (1993) 4.01
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
Myc activates telomerase. Genes Dev (1998) 3.74
New light on Myc and Myb. Part I. Myc. Genes Dev (1990) 3.57
Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc Natl Acad Sci U S A (1990) 3.31
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene (1999) 3.17
Growth factor-induced delayed early response genes. Mol Cell Biol (1992) 3.03
36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res (1991) 2.96
Ornithine decarboxylase activity is critical for cell transformation. Nature (1992) 2.92
Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol (1982) 2.89
Max: functional domains and interaction with c-Myc. Genes Dev (1992) 2.88
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J (1998) 2.86
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J (1996) 2.86
CDC25 phosphatases as potential human oncogenes. Science (1995) 2.84
Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol (1997) 2.62
Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell (1984) 2.43
Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci U S A (1994) 2.34
Myc target genes. Trends Biochem Sci (1997) 2.34
Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem (1988) 2.30
Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci U S A (1993) 2.29
Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell (1987) 2.27
SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin. EMBO J (1993) 2.27
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol (1995) 2.22
An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol (1996) 2.22
Determination of the c-MYC DNA-binding site. Proc Natl Acad Sci U S A (1991) 2.19
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science (1999) 2.17
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell (1995) 2.12
myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res (1991) 2.08
An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08
Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol Cell Biol (1997) 1.92
Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization. Mol Cell Biol (1991) 1.84
Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82
An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev (1992) 1.82
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene (1994) 1.73
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci U S A (1993) 1.70
Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res (1993) 1.61
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene (1995) 1.61
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res (1989) 1.61
On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett (1983) 1.59
Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol (1994) 1.55
Sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci U S A (1991) 1.55
SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein. Cell (1995) 1.54
Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev (1996) 1.54
Multivalent DNA-binding properties of the HMG-1 proteins. Proc Natl Acad Sci U S A (1996) 1.51
Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol (1992) 1.39
An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol Cell Biol (1994) 1.38
Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res (1993) 1.29
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res (1985) 1.27
Opposite orientations of DNA bending by c-Myc and Max. Proc Natl Acad Sci U S A (1992) 1.27
Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J Biol Chem (1993) 1.25
Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res (1991) 1.18
Ultrabithorax protein is necessary but not sufficient for full activation of decapentaplegic expression in the visceral mesoderm. EMBO J (1995) 1.16
Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteins. Genomics (1992) 1.13
Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. Hum Mol Genet (1997) 1.12
Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res (1993) 1.12
Recombinant circle PCR and recombination PCR for site-specific mutagenesis without PCR product purification. Biotechniques (1992) 1.11
The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex. Cold Spring Harb Symp Quant Biol (1993) 1.10
A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. Br J Cancer (1996) 1.07
ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc Natl Acad Sci U S A (1996) 1.06
Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein. Eur J Biochem (1991) 1.06
Selective decrease in low-Mr HMG proteins HMG I and HMG Y during differentiation of mouse teratocarcinoma cells. FEBS Lett (1988) 1.04
Myc meets its Max. Cell (1991) 1.04
High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur J Biochem (1993) 1.03
Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res (1997) 0.97
A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein. Biochem Biophys Res Commun (1995) 0.88
Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA Cell Biol (1997) 0.86
Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J Biol Chem (1995) 0.86
The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Mol Cell Biol (1999) 0.84
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA (1994) 17.56
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Phytochromes: photosensory perception and signal transduction. Science (1995) 7.91
Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol (2000) 7.74
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
Now is the time to retire the term "organic mental disorders". Am J Psychiatry (1992) 4.62
Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA (1995) 4.40
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell (1993) 4.15
Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science (2000) 4.12
Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol (1992) 4.02
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J Immunol (1991) 3.99
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
The difficult patient: prevalence, psychopathology, and functional impairment. J Gen Intern Med (1996) 3.83
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci U S A (1997) 3.71
Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol (2000) 3.51
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Psychotic disorders in DSM-III-R. Am J Psychiatry (1989) 3.15
Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med (2000) 3.12
Growth factor-induced delayed early response genes. Mol Cell Biol (1992) 3.03
Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med (1994) 3.02
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (1997) 2.98
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci U S A (1995) 2.83
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology (2009) 2.76
Mapping quantitative trait loci for yield, yield components and morphological traits in an advanced backcross population between Oryza rufipogon and the Oryza sativa cultivar Jefferson. Theor Appl Genet (2003) 2.76
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry (1997) 2.70
Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am (2006) 2.68
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development (1997) 2.66
DNA repair is more important than catalase for Salmonella virulence in mice. J Clin Invest (1995) 2.56
Discovering and understanding genes in human DNA sequence using GRAIL. Methods Enzymol (1996) 2.53
Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry (2007) 2.53
Retracted Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science (2001) 2.52
C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol (2000) 2.49
On the use of thiol-modifying agents to determine channel topology. Neuropharmacology (1996) 2.47
Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc Natl Acad Sci U S A (1999) 2.44
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44
Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology (2010) 2.39
p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J (2000) 2.38
Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron (1990) 2.38
SPA1: a new genetic locus involved in phytochrome A-specific signal transduction. Plant Cell (1998) 2.28
Nuclear emissions during self-nucleated acoustic cavitation. Phys Rev Lett (2006) 2.28
Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science (1996) 2.25
Agriculture. Increased food and ecosystem security via perennial grains. Science (2010) 2.25
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
Cloning and characterization of ftsN, an essential cell division gene in Escherichia coli isolated as a multicopy suppressor of ftsA12(Ts). J Bacteriol (1993) 2.22
A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev (1998) 2.19
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest (2000) 2.17
Late luteal phase dysphoric disorder and DSM-III-R. Am J Psychiatry (1989) 2.15
Retention of unassembled components of integral membrane proteins by calnexin. Science (1994) 2.15
Sexual isolation in Drosophila melanogaster: a possible case of incipient speciation. Proc Natl Acad Sci U S A (1995) 2.14
Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients. Psychol Med (2001) 2.12
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Effect of ADP and ionic strength on the kinetic and motile properties of recombinant mouse myosin V. J Biol Chem (2000) 2.09
Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology (2007) 2.09
Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med (1990) 2.06
Mutations in ftsZ that confer resistance to SulA affect the interaction of FtsZ with GTP. J Bacteriol (1994) 1.96
Information for Mandarin tones in the amplitude contour and in brief segments. Phonetica (1992) 1.92
Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proc Natl Acad Sci U S A (2001) 1.91
COMO: a program for combined molecular replacement. Acta Crystallogr D Biol Crystallogr (2001) 1.91
P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol (2001) 1.86
The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect (1998) 1.86
The bacterially expressed yeast CDC34 gene product can undergo autoubiquitination to form a multiubiquitin chain-linked protein. J Biol Chem (1993) 1.86
Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur J Neurosci (2001) 1.84
Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization. Mol Cell Biol (1991) 1.84
B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J (1993) 1.82
CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine (2000) 1.80
Propanediol utilization genes (pdu) of Salmonella typhimurium: three genes for the propanediol dehydratase. J Bacteriol (1997) 1.80
Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci U S A (2000) 1.80
ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants. J Biol Chem (1995) 1.80
Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol (2000) 1.80
Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J Cell Biol (1995) 1.76
Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem (2000) 1.74
SMN2-deletion in childhood-onset spinal muscular atrophy. Am J Med Genet (2001) 1.74
Activities of constitutive promoters in Escherichia coli. J Mol Biol (1999) 1.70
Microsatellite marker development, mapping and applications in rice genetics and breeding. Plant Mol Biol (1997) 1.68
Sorption of zn2+ and cd2+ on hydroxyapatite surfaces. Environ Sci Technol (1994) 1.68
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
Topological characterization of the essential Escherichia coli cell division protein FtsN. J Bacteriol (1996) 1.67
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem (2001) 1.65
Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology (2004) 1.65
Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol (2002) 1.65
Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry (1997) 1.64
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res (2001) 1.64
Thermoanaerobacter tengcongensis sp. nov., a novel anaerobic, saccharolytic, thermophilic bacterium isolated from a hot spring in Tengcong, China. Int J Syst Evol Microbiol (2001) 1.64
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Experimental study of the protein folding landscape: unfolding reactions in cytochrome c. J Mol Biol (1999) 1.59
Clinical determinants of dementia related to stroke. Ann Neurol (1993) 1.58
Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther (2010) 1.58
Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS (1999) 1.58